CAS 883715-18-2

Formule : C25H37NO

InChI : InChI=1S/C25H37NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-25(27)26-23-24-20-17-16-18-21-24/h3-4,6-7,9-10,16-18,20-21H,2,5,8,11-15,19,22-23H2,1H3,(H,26,27)/b4-3-,7-6-,10-9-

Code InChI : VCMMYRWIEZCYDK-PDBXOOCHSA-N

SMILES : CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)NCC1=CC=CC=C1

N-Benzyllinolenamide

CAS : 883715-18-2

N-Benzyllinolenamide

Formule : C₂₅H₃₇NO

Degré de pureté : ≥98%

Masse moléculaire : 367.57

Ref: 54-BUP07070

N-Benzyllinolenamide

CAS : 883715-18-2

Formule : C₂₅H₃₇NO

Masse moléculaire : 367.58

Ref: 7W-GY4702

N-Benzyllinolenamide

CAS : 883715-18-2

Formule : C₂₅H₃₇NO

Degré de pureté : 95%~99%

Masse moléculaire : 367.577

Ref: BP-SBP04343

N-Benzyllinolenamide

CAS : 883715-18-2

Formule : C₂₅H₃₇NO

Degré de pureté : 98%

Masse moléculaire : 367.5674

Ref: IN-DA00H1MA

N-​Benzyllinolenamide

CAS : 883715-18-2

N-Benzyllinolenamide is a natural product. It is an inhibitor of fatty acid amide hydrolase (FAAH, IC50 of 41.8 μM).

Formule : C₂₅H₃₇NO

Degré de pureté : 98.7% - 99.92%

Couleur et forme : Solid

Masse moléculaire : 367.5674

Ref: TM-TN1965

N-benzyl-9Z,12Z,15Z-octadecatrienamide

CAS : 883715-18-2

N-benzyl-9Z,12Z,15Z-octadecatrienamide (NBDOT) is a cannabimimetic compound that was synthesized to investigate the role of mitochondria in neurodegenerative diseases. NBDOT binds to protein targets in the mitochondria and inhibits their function. This leads to an increase in free fatty acids and endocannabinoids, as well as potent inhibition of CB1 receptor activity. These activities have been demonstrated using in vivo studies on rats. NBDOT also has a potent inhibitory effect on fatty acid amide hydrolase, which is involved in the degradation of endocannabinoids.

Formule : C₂₅H₃₇NO

Degré de pureté : Min. 95%

Masse moléculaire : 367.57 g/mol

Ref: 3D-FB74463